Allogene Therapeutics
Allogene Therapeutics is a San Francisco, California-based biotechnology company specializing in the development of allogeneic CAR T("AlloCAR TTM") therapies for cancer.
Apple App Store URL
B2X
CFO
CIK Number
Legal Name
Allogene Therapeutics, Inc.
Company Operating Status
Active
Contact Page URL
Country
Crunchbase URL
Email Address
info@allogene.com
0
Founded Date
2017
Founder
Full Address
210 E Grand Ave, South San Francisco, California 94080, US
0
Google Play Store URL
IRS Number
823,562,771
0
Latest Funding Round Date
2018
Latest Funding Round Amount (USD)
300,000,000
Latest Funding Type
LinkedIn URL
Number of Employees
334
Number of Employees (Ranges)
201 – 500
0
Patents Assigned (Count)
1
Phone Number
+16504572700
0
Pitchbook URL
Public/Private
Public
0
SIC Code
2,836
0
Exchange
Stock Symbol
ALLO
0
Technologies Used
Ticker Symbol
ALLO
Total Funding Amount (USD)
300,000,000
Twitter URL
Official Website
Find more companies like Allogene Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.